Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga May 02, 2014 at 08:53 AM EDT Endocyte (NASDAQ: ECYT) shares fell 61.16% to $6.75 in pre-market trading after the company reported first quarter financial results and ... Read More >> Related Stocks: CVS Health Corp Endocyte Inc Expedia Servicesrce Intl Inc